1). Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. 1991. Bull World Health Organ. 2001. 79:71–5.
2). The World Health Organization: Tuberculosis. Fact sheet number 104. 2006.
3). Bloom BR., Small PM. The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med. 1998. 338:677–8.
4). Jo EK., Park JK., Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis. 2003. 16:205–10.
Article
5). Jo EK., Yang CS., Choi CH., Harding CV. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol. 2007. 9:1087–98.
Article
6). Roy S., Sharma S., Sharma M., Aggarwal R., Bose M. Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis. Immunology. 2004. 112:471–80.
7). Aslan M., Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal. 2003. 5:781–8.
Article
8). Chandel NS., Budinger GR. The cellular basis for diverse responses to oxygen. Free Radic Biol Med. 2007. 42:165–74.
Article
9). Poli G., Leonarduzzi G., Biasi F., Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem. 2004. 11:1163–82.
Article
10). Lee HM., Shin DM., Kim KK., Lee JS., Paik TH., Jo EK. Roles of reactive oxygen species in CXCL8 and CCL2 expression in response to the 30-kDa antigen of Mycobacterium tuberculosis. J Clin Immunol. 2009. 29:46–56.
11). Yang CS., Shin DM., Lee HM., Son JW., Lee SJ., Akira S., Gougerot-Pocidalo MA., El-Benna J., Ichijo H., Jo EK. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell Microbiol. 2008. 10:741–54.
Article
12). Yuk JM., Shin DM., Yang CS., Kim KH., An SJ., Rho J., Park JK., Jo EK. Role of apoptosis-regulating signal kinase 1 in innate immune responses by Mycobacterium bovis bacillus Calmette-Guerin. Immunol Cell Biol. 2009. 87:100–7.
13). Méndez-Samperio P., Trejo A., Pérez A. Mycobacterium bovis Bacillus Calmette-Guerin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells. Cell Immunol. 2008. 251:37–42.
14). Méndez-Samperio P., Miranda E., Trejo A. Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guerin. Clin Vaccine Immunol. 2008. 15:1450–5.
15). Schorey JS., Cooper AM. Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell Microbiol. 2003. 5:133–42.
Article
16). Yang CS., Lee JS., Song CH., Hur GM., Lee SJ., Tanaka S., Akira S., Paik TH., Jo EK. Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2. Cell Microbiol. 2007. 9:382–96.
17). Song CH., Lee JS., Lee SH., Lim K., Kim HJ., Park JK., Paik TH., Jo EK. Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-alpha, interleukin-10, and monocyte chemotactic protein-1 by Mycobacterium tuberculosis H37Rv-infected human monocytes. J Clin Immunol. 2003. 23:194–201.
18). Jung SB., Yang CS., Lee JS., Shin AR., Jung SS., Son JW., Harding CV., Kim HJ., Park JK., Paik TH., Song CH., Jo EK. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect Immun. 2006. 74:2686–96.
Article
19). Martindale JL., Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol. 2002. 192:1–15.
Article
20). Yodoi J., Masutani H., Nakamura H. Redox regulation by the human thioredoxin system. Biofactors. 2001. 15:107–11.
Article
21). Gribar SC., Anand RJ., Sodhi CP., Hackam DJ. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol. 2008. 83:493–8.
Article
22). Schmeck B., Huber S., Moog K., Zahlten J., Hocke AC., Opitz B., Hammerschmidt S., Mitchell TJ., Kracht M., Rosseau S., Suttorp N., Hippenstiel S. Pneumococci induced TLR- and Rac1-dependent NF-kappaB-recruitment to the IL-8 promoter in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006. 290:L730–7.
23). Guillot L., Medjane S., Le-Barillec K., Balloy V., Danel C., Chignard M., Si-Tahar M. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling path-ways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem. 2004. 279:2712–8.
24). Armstrong L., Medford AR., Uppington KM., Robertson J., Witherden IR., Tetley TD., Millar AB. Expression of functional toll-like receptor-2 and −4 on alveolar epithelial cells. Am J Respir Cell Mol Biol. 2004. 31:241–5.
Article
25). Flynn JL., Goldstein MM., Chan J., Triebold KJ., Pfeffer K., Lowenstein CJ., Schreiber R., Mak TW., Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995. 2:561–72.
26). Mohan VP., Scanga CA., Yu K., Scott HM., Tanaka KE., Tsang E., Tsai MM., Flynn JL., Chan J. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun. 2001. 69:1847–55.
Article
27). Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990. 8:253–78.
Article
28). Flesch IE., Kaufmann SH. Stimulation of antibacterial macrophage activities by B-cell stimulatory factor 2 (interleukin-6). Infect Immun. 1990. 58:269–71.
Article
29). VanHeyningen TK., Collins HL., Russell DG. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol. 1997. 158:330–7.
30). Serbina NV., Jia T., Hohl TM., Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008. 26:421–52.
Article
31). Lin Y., Zhang M., Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun. 1998. 66:1121–6.
32). Baggiolini M., Walz A., Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989. 84:1045–9.
Article
33). Larsen CG., Anderson AO., Appella E., Oppenheim JJ., Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 1989. 243:1464–6.
Article
34). Leonard EJ., Skeel A., Yoshimura T., Noer K., Kutvirt S., Van Epps D. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol. 1990. 144:1323–30.
35). Zhang Y., Broser M., Cohen H., Bodkin M., Law K., Reibman J., Rom WN. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest. 1995. 95:586–92.
36). Nibbering PH., Pos O., Stevenhagen A., Van Furth R. Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes. Infect Immun. 1993. 61:3111–6.
37). Larsen CG., Thomsen MK., Gesser B., Thomsen PD., Deleuran BW., Nowak J., Sk⊘dt V., Thomsen HK., Deleuran M., Thestrup-Pedersen K. The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J Immunol. 1995. 155:2151–7.
38). Obata T., Brown GE., Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med. 2000. 28:N67–77.
Article
39). Sun T., Dittmar K., Koduru P., Susin M., Teichberg S., Brody J. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. Am J Hematol. 1996. 51:282–8.
Article
40). Kim H., Hwang JS., Woo CH., Kim EY., Kim TH., Cho KJ., Kim JH., Seo JM., Lee SS. TNF-alpha-induced up-regulation of intercellular adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway epithelial cells. Exp Mol Med. 2008. 40:167–75.
41). Zhao Y., Usatyuk PV., Gorshkova IA., He D., Wang T., Moreno-Vinasco L., Geyh AS., Breysse PN., Samet JM., Spannhake EW., Garcia JG., Natarajan V. Regulation of COX-2 expression and IL-6 release by particulate matter in airway epithelial cells. Am J Respir Cell Mol Biol. 2009. 40:19–30.
Article
42). Coburn J., Frank DW. Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system. Infect Immun. 1999. 67:3151–4.